Bulletin Nº61 - July 2015

CYTOGENETICS - Genetic markers in the myeloproliferative syndromes classification
Myeloproliferative neoplasms (NMP) are clonal disorders of hematopoietic precursor cells, characterized by the proliferation of myeloid or more lines. Classically, the NMP were subdivided according to whether the Philadelphia chromosome (BCR / ABL1), confirming a chronic myeloid leukemia (CML), or if the patient was BCR / ABL1 negative, was detected using clinical criteria. Currently, the study of mutational status of JAK2, MPL and CALR genes, plays an important role in the classification of different subtypes of NMP.
Genetic markers in the myeloproliferative syndromes classification

Bulletin Nº51 - June 2014

CYTOGENETICS - Array-CGH
Array-CGH technology detects dose changes (copy number changes or CNV), along the whole genome. The technique is based on the competitive hybridization between a reference DNA and a patient DNA.
Array-CGH

Bulletin Nº47 - February 2014

MOLECULAR BIOLOGY - Change of method in celiac disease molecular study
Celiac disease is a chronic inflammatory bowel disease that affects from 1 to 3% of the Western population. At the molecular level, is associated with the HLA genes. From December 2013 we incorporated a new equipment that allows us to make a complete study of the two genetic regions associated with celiac disease (HLA-DQA/HLA-DQB). This equipment is designed to work with reverse hybridization technique adapted to a microarray plate, and also allows us to determine if these alleles are in heterozygous or homozygous state.
Change of method in celiac disease molecular study

Bulletin Nº46 - January 2014

CYTOGENETICS - New method of noninvasive prenatal screening. Study of fetal aneuploidy in maternal blood
Based on the study of circulating fetal DNA in maternal blood, new techniques have been developed for prenatal aneuploidy screening with high sensitivity and specificity.
New Method of Fetal Aneuploidy Screening

Bulletin Nº36 - February 2013

CYTOGENETICS - Document of informed consent for genetic testing
For testing oriented genetic diagnosis, is necessary and required that patients know the implications of these tests before implementation, and the best guarantee that this process will be appropriate is the informed consent document.
Informed consent for genetic testing

Bulletin Nº 32 - October 2012

MOLECULAR BIOLOGY - Method change for the molecular study of the HFE mutation gen, related with hereditary hemochromatosis
Hereditary hemochromatosis (HH) is a genetic disease of autosomal recessive transmission wich causes an alteration in iron metabolism.
Method change for the molecular study of the HFE mutation gen

Bulletin Nº27 - April 2012

CYTOGENETICS–Cytogenetic study of byproducts of miscarriage. Approximately 10-15% of clinically recognized pregnancies end in miscarriage, the majority of which are produced in the first trimester, and 50% of these are associated with chromosomal anomalies.
Cytogenetic study of byproducts of miscarriage

Bulletin Nº14 - February 2011

MOLECULAR BIOLOGY –Phenotype and Genotype of HLA-B27 The presence of the antigen HLA-B27 has been closely associated for more than 30 years with Ankylosing Spondylitis.
Phenotypeand Genotype of HLA-B27

Bulletin Nº12 - December 2010

CYTOGENETIC - Y chromosome microdeletions
Infertility is a problem that affects 10-20% of couples. In some cases, the cause is microdeletions in the distal portion of chromosome Y.
Cromosome Y Microdeletions

Bulletin Nº 10 - October 2010

Cytogenetics - Quantification of BCR-ABL reorganitation
There are some recurring cytogenetic abnormalities hematologic malignant diseases, and the first to be described was the translocation t (9; 22) (q34, q11
Quantification of BCR-ABL reorganitzación